Lonza Group has appointed Marc Funk as COO of the Pharma and Biotech segment. “Funk has been the Group’s Chief Legal Officer and Board Secretary since 2009 and a member of the EC since 2012,” said Richard Ridinger, Chief Executive Officer, Lonza. “He has already successfully managed operational and commercial projects in the Pharma and Biotech network and has been responsible for Global Quality in Pharma and Biotech for more than a year. Also, he has broad experience in this field as he was formerly co-founder of a biotech research company and has had a strong commercial focus in other parts of his career. I am confident he’ll be able to steer that segment through this critical growth phase and into the future.”
During the transition period, Funk will continue as the Group’s Chief Legal Officer and Board Secretary until his successor for this role is announced in due course.
EP News Bureau– Mumbai